Introduction
============

Classification criteria are needed to aid recruitment of appropriate patients into research studies. The International Myositis Classification Criteria Project (IMCCP) was set up with support from ACR and EULAR.

Objectives
==========

To develop and validate new classification criteria for adult and juvenile IIM.

Methods
=======

Candidate criteria variables were taken from published criteria and inclusion criteria from clinical trials of myositis. Comparator groups confused with IIM were defined. Clinical and laboratory data from IIM and comparator patients were collected from 47 rheumatology, dermatology, neurology and pediatrics clinics worldwide from 2008-2011.

Pair-wise associations among all items and between each item and clinicians' diagnoses were assessed. Three approaches for derivation of classification criteria were explored: Traditional, Probability score and Classification tree.

Internal validation using bootstrap methods and external validation using data from the Euromyositis register and the Juvenile Dermatomyositis cohort biomarker study and repository UK and Ireland was performed.

Results
=======

976 IIM (74% adults; 26% children) and 624 comparators (81% adults; 19% children) were obtained.

The new criteria comprise clinical items on muscles, skin, and laboratory measures. Muscle biopsy features can be included. Each item has an assigned score, the total score corresponds to the probability of having IIM. Each probability has specific sensitivity/specificity measures making it possible to use individual inclusion criteria for clinical studies. If no skin rash is present a muscle biopsy is mandatory. High probability of IIM is considered if the score \> 7.5 (or \> 8.7 if no skin rash), with minimum probability cutoff of 50% (score 5.3 or 6.5). Table [1](#T1){ref-type="table"}.

###### 

Performance of new and exisiting classification / diagnostic criteria for idiopathic inflammatory myopathies

  Performance (%)        New classification criteria^a^   Peter & Bohan \[1\]^b^   Tanimoto *et al.* \[2\]   Targoff *et al.* \[3\]^b^   Dalakas & Hohlfeld \[4\]^b^   Hoogendijk *et al.* \[5\]^b^   
  ---------------------- -------------------------------- ------------------------ ------------------------- --------------------------- ----------------------------- ------------------------------ ----
  Sensitivity            91                               94                       98                        96                          93                            6                              51
  Specificity            82                               85                       55                        31                          88                            99                             96
  Correctly classified   88                               91                       86                        79                          91                            45                             70

^a^ Cut point for probability: 55%

^b^ Definite and probable polymyositis and dermatomyositis

External validation using data on 592 adult or 332 juvenile IIM patients yielded 100% sensitivity.

Conclusion
==========

The new classification criteria for IIM have easy-to-access items and show generally superior performance compared to existing criteria. Approval for these will be sought from ACR/EULAR.
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